Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Skinvisible (SKVI) over the last 17 years, with Q3 2025 value amounting to $111057.0.

  • Skinvisible's Operating Expenses fell 1455.12% to $111057.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $600889.0, marking a year-over-year increase of 977.47%. This contributed to the annual value of $609589.0 for FY2024, which is 1943.94% up from last year.
  • Skinvisible's Operating Expenses amounted to $111057.0 in Q3 2025, which was down 1455.12% from $141237.0 recorded in Q2 2025.
  • Skinvisible's Operating Expenses' 5-year high stood at $203743.0 during Q4 2024, with a 5-year trough of $105315.0 in Q4 2021.
  • Moreover, its 5-year median value for Operating Expenses was $128184.0 (2024), whereas its average is $131688.2.
  • Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 1791.65% in 2021, then soared by 4394.93% in 2024.
  • Quarter analysis of 5 years shows Skinvisible's Operating Expenses stood at $105315.0 in 2021, then grew by 16.52% to $122716.0 in 2022, then grew by 15.34% to $141538.0 in 2023, then skyrocketed by 43.95% to $203743.0 in 2024, then plummeted by 45.49% to $111057.0 in 2025.
  • Its last three reported values are $111057.0 in Q3 2025, $141237.0 for Q2 2025, and $144852.0 during Q1 2025.